EOLS

Evolus is a commercial-stage aesthetic medicine company focused on injectable neurotoxins and injectable hyaluronic acid gels for the cash-pay aesthetic market. Jeuveau, a purified botulinum toxin type A formulation approved in the United States, Canada, Europe, Australia, and Switzerland, is indicated for temporary improvement of moderate to severe glabellar lines. Evolysse, a portfolio of injectable hyaluronic acid gels utilizing cold technology, recently received FDA approval for Evolysse Form and Evolysse Smooth in the United States and European Union approval for four products, with additional products expected to receive regulatory approval through 2027.

Pipeline

Catalyst Calendar